
Advancing Gene Therapies: FDA's Milestone Approval for Duchenne Muscular Dystrophy Treatment

The Rise of iPSCs in Drug Discovery: Regulatory and Legislative Changes Driving the Shift from Animal Models

FDA Modernization Act 2.0: FDA no longer requires all drugs to be tested on animals before human trials

Projects on Organ-on-Chip technology awarded a grant

Ncardia Launches iPSC-Based Drug Discovery Screening Service